Wamda Capital Invests in Salus’ $4.7 Million Seed Round
The new capital injection will be used to expand the Turkey-based healthtech clinical network, enhance user experience, and scale its B2B business.
Turkey-based healthtech startup, Salus, announced that it has secured $4.7 million seed investment round, bringing its total fundraising since inception to more than $5.5 million, as per the company's press release.[1]
Northzone led this oversubscribed round, among other participants including 500 Emerging Europe, Pitchdrive, and the CVC division of Turkish İş Bank.
In addition, Collective Spark and Wamda Capital doubled down their investments in Salus via this round.
Other angel investors included Fırat İleri (Hummingbird Ventures), Adam Anders (Anterra Capital), İnanç Balcı (Crestone VC & Lazada), Egem Eraslan (Midas) Can Yücaoğlu (MAP Investment), Mehmet Yılmaz (Freeletics & Zavvy), Joshua Cornelius (Freeletics & Zavvy) and Kıvanç Semen (Dataguard).
Salus provides a science-backed strategy to convince employers to support their workers' mental health by providing a significant return on investment and boosting well-being across the board.
In the long run, the platform eyes becoming a one-stop station that offers a user-centric healthcare experience by branching out into nutrition and physical health services.
Salus, founded in 2022 by Alperen Adikti and Bahar Ayberk, two ex-McKinsey consultants with extensive experience in healthcare, and insurance, in the region. The company provides a wide range of services, including self-care content and coaching and therapy sessions.
The new capital injection will help in strengthening Salus’ clinical network, investing in technology and user experience, and scaling B2B business development efforts to solidify its market presence.
